HB 201 (2022): relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 201 (2022): relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders.” Granite Record, https://graniterecord.org/bill/2022/hb201. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 201 (2022): relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/hb201
Chicago
Granite Record. “HB 201 (2022): relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/hb201.
BibTeX
@misc{bill-2022-hb201, title = {HB 201 (2022): relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/hb201}, note = {Accessed 24 Oct. 2026} }

HB 201 (2022)

relative to review by the insurance department of coverage for pediatric autoimmune neuropsychiatric disorders.

  • Status: Killed
  • Term: 2021-2022
  • House committee: Commerce and Consumer Affairs
  • Subject: Insurance

The Story

It was introduced on January 6, 2021 and referred to the House Commerce and Consumer Affairs committee. The committee met in executive session on February 10, 2021 to vote on its recommendation. The committee retained the bill, holding it for further work rather than reporting it out this year. The committee held work sessions on September 21, 2021 and October 12, 2021. The committee met in executive session on October 26, 2021 to vote on its recommendation. The committee voted 18–1 to recommend that the House kill it, and the report was placed on the consent calendar. On January 5, 2022 the House voted to kill it on a voice vote.

Sponsors

Hearings and Sessions

  • February 2, 2021, 1:45 PM: public hearing, House Commerce and Consumer Affairs
  • February 10, 2021, 1:40 PM: executive session, House Commerce and Consumer Affairs
  • September 21, 2021, 10:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
  • October 12, 2021, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 301-303
  • October 26, 2021, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB306-308

Votes

  • January 5, 2022, House: Inexpedient to Legislate — voice vote, passed

The Docket

  • January 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Commerce and Consumer Affairs
  • February 2, 2021: Public Hearing: 02/02/2021 01:45 pm Members of the public may attend using the following links: To join the webinar: https://www.zoom.us/j/92235067141 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened
  • February 10, 2021: Executive Session: 02/10/2021 01:40 pm Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/95521072179
  • March 23, 2021: Retained in Committee
  • September 21, 2021: Subcommittee Work Session: 09/21/2021 10:30 am LOB 302-304
  • October 12, 2021: Subcommittee Work Session: 10/12/2021 09:00 am LOB 301-303
  • October 26, 2021: Executive Session: 10/26/2021 10:00 a.m. LOB306-308
  • November 1, 2021: Committee Report: Inexpedient to Legislate HB201 11/01/2021 (Vote 18-1; CC)
  • January 5, 2022: Inexpedient to Legislate: MA VV 01/05/2022

From the General Court